Here's Why This Under-the-Radar Biotech Is at the Top of My Buy List
4/3 17:30
Vir Bio (NASDAQ: VIR) is one of the strongest buying opportunities I see in the market today. The company's COVID-19 treatment, Xevudy, works against the omicron variant. So the U.S. and other governments are spending a lot of money buying supplies of the drug, which runs about $...